SCHEMBL572073

SCHEMBL572073

CC1=C(CCC(C)CCCC(C)CCCC(C)CCCC(C)CCCC(C)CCCC(C)C)C(=O)c2ccccc2C1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.63
PDE4A P27815 1/20 0.63
SNCA P37840 1/20 0.63
PDE3A Q14432 1/20 0.63
CDC25B P30305 4/20 0.50
PTPN2 P17706 1/20 0.50
PTPN1 P18031 1/20 0.50
DHODH Q02127 1/20 0.48
IDO1 P14902 1/20 0.46
LMNA P02545 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
HTT P42858 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
APAF1 O14727 1/20 0.43
MITF O75030 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TBXAS1 P24557 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL572130 1.00 PTGS1 (0.63) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL571987 1.00 PTGS1 (0.63) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL12473794 1.00 PTGS1 (0.63) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL17296075 1.00 PTGS1 (0.63) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL571611 1.00 PTGS1 (0.63) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL571963 1.00 PTGS1 (0.63) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL571584 1.00 PTGS1 (0.63) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL571484 0.87 DHODH (0.60) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL11785688 0.87 PDE3A (0.52) PTGS1PDE4ASNCAPDE3ACDC25B
SCHEMBL571066 0.87 PTGS1 (0.49) PTGS1PDE4ASNCAPDE3ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015183985-A2 THERAPEUTIC COMPOSITIONS INCLUDING NAPHTHOQUINONES AND USES THEREOF STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-12-03 WO disclosed
EP-2600857-A2 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES Edison Pharmaceuticals, Inc. (US) 2013-06-12 EP disclosed
WO-2012019029-A2 TREATMENT OF MITOCHONDRIAL DISEASES WITH NAPHTHOQUINONES EDISON PHARMACEUTICALS, INC. (US) 2012-02-09 WO disclosed